skip to main content
Language:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters

Results 1 - 20 of 52,102  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Refined by: subject: Adult remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Abbreviated Breast Magnetic Resonance Imaging (MRI): First Postcontrast Subtracted Images and Maximum-Intensity Projection—A Novel Approach to Breast Cancer Screening With MRI
Material Type:
Article
Add to My Research

Abbreviated Breast Magnetic Resonance Imaging (MRI): First Postcontrast Subtracted Images and Maximum-Intensity Projection—A Novel Approach to Breast Cancer Screening With MRI

Journal of clinical oncology, 2014-08, Vol.32 (22), p.2304-2310 [Peer Reviewed Journal]

2015 INIST-CNRS ;2014 by American Society of Clinical Oncology. ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2013.52.5386 ;PMID: 24958821

Full text available

2
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
Material Type:
Article
Add to My Research

Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer

The New England journal of medicine, 2016-12, Vol.375 (22), p.2154-2164 [Peer Reviewed Journal]

Copyright © 2016 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1611310 ;PMID: 27717299

Full text available

3
Tumor-Infiltrating CD8+ Lymphocytes Predict Clinical Outcome in Breast Cancer
Material Type:
Article
Add to My Research

Tumor-Infiltrating CD8+ Lymphocytes Predict Clinical Outcome in Breast Cancer

Journal of clinical oncology, 2011-05, Vol.29 (15), p.1949-1955 [Peer Reviewed Journal]

2015 INIST-CNRS ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2010.30.5037 ;PMID: 21483002

Full text available

4
Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial
Material Type:
Article
Add to My Research

Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial

Annals of oncology, 2014-08, Vol.25 (8), p.1544-1550 [Peer Reviewed Journal]

2014 European Society for Medical Oncology ;2015 INIST-CNRS ;The Author 2014. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com. ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdu112 ;PMID: 24608200

Full text available

5
The burden of endometriosis: costs and quality of life of women with endometriosis and treated in referral centres
Material Type:
Article
Add to My Research

The burden of endometriosis: costs and quality of life of women with endometriosis and treated in referral centres

Human reproduction (Oxford), 2012-05, Vol.27 (5), p.1292-1299 [Peer Reviewed Journal]

The Author 2012. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oup.com 2012 ;2015 INIST-CNRS ;ISSN: 0268-1161 ;EISSN: 1460-2350 ;DOI: 10.1093/humrep/des073 ;PMID: 22422778 ;CODEN: HUREEE

Full text available

6
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial
Material Type:
Article
Add to My Research

Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial

The Lancet (British edition), 2013-03, Vol.381 (9869), p.805-816 [Peer Reviewed Journal]

Elsevier Ltd ;2014 INIST-CNRS ;Copyright Elsevier Limited Mar 9, 2013 ;2013 Elsevier Ltd. All rights reserved. 2013 Elsevier Ltd ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(12)61963-1 ;PMID: 23219286 ;CODEN: LANCAO

Full text available

7
Breast-Cancer Risk in Families with Mutations in PALB2
Material Type:
Article
Add to My Research

Breast-Cancer Risk in Families with Mutations in PALB2

The New England journal of medicine, 2014-08, Vol.371 (6), p.497-506 [Peer Reviewed Journal]

Copyright © 2014 Massachusetts Medical Society. All rights reserved. ;2015 INIST-CNRS ;Copyright © 2014 Massachusetts Medical Society. 2014 ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1400382 ;PMID: 25099575 ;CODEN: NEJMAG

Full text available

8
Prospective Study of Fertility Concerns and Preservation Strategies in Young Women With Breast Cancer
Material Type:
Article
Add to My Research

Prospective Study of Fertility Concerns and Preservation Strategies in Young Women With Breast Cancer

Journal of clinical oncology, 2014-04, Vol.32 (11), p.1151-1156 [Peer Reviewed Journal]

2015 INIST-CNRS ;2014 by American Society of Clinical Oncology 2014 ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2013.52.8877 ;PMID: 24567428

Full text available

9
Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in a Phase III Randomized Adjuvant Breast Cancer Trial in Node-Positive Breast Cancer Comparing the Addition of Docetaxel to Doxorubicin With Doxorubicin-Based Chemotherapy: BIG 02-98
Material Type:
Article
Add to My Research

Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in a Phase III Randomized Adjuvant Breast Cancer Trial in Node-Positive Breast Cancer Comparing the Addition of Docetaxel to Doxorubicin With Doxorubicin-Based Chemotherapy: BIG 02-98

Journal of clinical oncology, 2013-03, Vol.31 (7), p.860-867 [Peer Reviewed Journal]

2014 INIST-CNRS ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2011.41.0902 ;PMID: 23341518

Full text available

10
Prognostic Value of a Combined Estrogen Receptor, Progesterone Receptor, Ki-67, and Human Epidermal Growth Factor Receptor 2 Immunohistochemical Score and Comparison With the Genomic Health Recurrence Score in Early Breast Cancer
Material Type:
Article
Add to My Research

Prognostic Value of a Combined Estrogen Receptor, Progesterone Receptor, Ki-67, and Human Epidermal Growth Factor Receptor 2 Immunohistochemical Score and Comparison With the Genomic Health Recurrence Score in Early Breast Cancer

Journal of clinical oncology, 2011-11, Vol.29 (32), p.4273-4278 [Peer Reviewed Journal]

2015 INIST-CNRS ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2010.31.2835 ;PMID: 21990413

Full text available

11
Association between CD8+ T-cell infiltration and breast cancer survival in 12 439 patients
Material Type:
Article
Add to My Research

Association between CD8+ T-cell infiltration and breast cancer survival in 12 439 patients

Annals of oncology, 2014-08, Vol.25 (8), p.1536-1543 [Peer Reviewed Journal]

2014 European Society for Medical Oncology ;2015 INIST-CNRS ;The Author 2014. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com. ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdu191 ;PMID: 24915873

Full text available

12
SUCCOR study: an international European cohort observational study comparing minimally invasive surgery versus open abdominal radical hysterectomy in patients with stage IB1 cervical cancer
Material Type:
Article
Add to My Research

SUCCOR study: an international European cohort observational study comparing minimally invasive surgery versus open abdominal radical hysterectomy in patients with stage IB1 cervical cancer

International journal of gynecological cancer, 2020-09, Vol.30 (9), p.1269-1277 [Peer Reviewed Journal]

IGCS and ESGO 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;2020 by the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology. ;2020 IGCS and ESGO 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1048-891X ;ISSN: 1525-1438 ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2020-001506 ;PMID: 32788262

Full text available

13
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
Material Type:
Article
Add to My Research

Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes

Journal of clinical oncology, 2009-03, Vol.27 (8), p.1160-1167 [Peer Reviewed Journal]

2009 INIST-CNRS ;2009 by American Society of Clinical Oncology 2009 ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2008.18.1370 ;PMID: 19204204

Full text available

14
Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer
Material Type:
Article
Add to My Research

Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer

Journal of clinical oncology, 2010-01, Vol.28 (1), p.105-113 [Peer Reviewed Journal]

2015 INIST-CNRS ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2009.23.7370 ;PMID: 19917869

Full text available

15
The benefits and harms of breast cancer screening: an independent review
Material Type:
Article
Add to My Research

The benefits and harms of breast cancer screening: an independent review

The Lancet (British edition), 2012-11, Vol.380 (9855), p.1778-1786 [Peer Reviewed Journal]

Elsevier Ltd ;2012 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2012 Elsevier Ltd. All rights reserved. ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(12)61611-0 ;PMID: 23117178 ;CODEN: LANCAO

Full text available

16
Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial
Material Type:
Article
Add to My Research

Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial

Journal of clinical oncology, 2014-05, Vol.32 (13), p.1302-1308 [Peer Reviewed Journal]

2015 INIST-CNRS ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2013.51.4489 ;PMID: 24637997

Full text available

17
Clinically Used Breast Cancer Markers Such As Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 Are Unstable Throughout Tumor Progression
Material Type:
Article
Add to My Research

Clinically Used Breast Cancer Markers Such As Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 Are Unstable Throughout Tumor Progression

Journal of clinical oncology, 2012-07, Vol.30 (21), p.2601-2608 [Peer Reviewed Journal]

2015 INIST-CNRS ;ISSN: 0732-183X ;ISSN: 1527-7755 ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2011.37.2482 ;PMID: 22711854

Full text available

18
Randomized Phase II Trial of Everolimus in Combination With Tamoxifen in Patients With Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer With Prior Exposure to Aromatase Inhibitors: A GINECO Study
Material Type:
Article
Add to My Research

Randomized Phase II Trial of Everolimus in Combination With Tamoxifen in Patients With Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer With Prior Exposure to Aromatase Inhibitors: A GINECO Study

Journal of clinical oncology, 2012-08, Vol.30 (22), p.2718-2724 [Peer Reviewed Journal]

2015 INIST-CNRS ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2011.39.0708 ;PMID: 22565002

Full text available

19
Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials
Material Type:
Article
Add to My Research

Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials

The Lancet (British edition), 2014-02, Vol.383 (9916), p.524-532 [Peer Reviewed Journal]

Elsevier Ltd ;2014 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2014 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Feb 8, 2014 ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(13)62218-7 ;PMID: 24192252 ;CODEN: LANCAO

Full text available

20
Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles
Material Type:
Article
Add to My Research

Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles

Human reproduction (Oxford), 2011-07, Vol.26 (7), p.1768-1774 [Peer Reviewed Journal]

The Author 2011. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oup.com 2011 ;2015 INIST-CNRS ;ISSN: 0268-1161 ;EISSN: 1460-2350 ;DOI: 10.1093/humrep/der106 ;PMID: 21558332 ;CODEN: HUREEE

Full text available

Results 1 - 20 of 52,102  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (50,913)

Refine My Results

Creation Date 

From To
  1. Before 1990  (5,725)
  2. 1990 To 1997  (12,269)
  3. 1998 To 2005  (16,895)
  4. 2006 To 2014  (17,192)
  5. After 2014  (22)
  6. More options open sub menu

Resource Type 

  1. Articles  (52,096)
  2. Web Resources  (6)
  3. More options open sub menu

Language 

  1. English  (52,096)
  2. Japanese  (6,758)
  3. French  (69)
  4. German  (60)
  5. Portuguese  (23)
  6. Chinese  (1)
  7. Swedish  (1)
  8. Norwegian  (1)
  9. More options open sub menu

Searching Remote Databases, Please Wait